[Contribution to acneiform eruptions by epidermal growth factor receptor inhibitors]

Actas Dermosifiliogr. 2006 Mar;97(2):148-9. doi: 10.1016/s0001-7310(06)73371-3.
[Article in Spanish]
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Acneiform Eruptions / chemically induced*
  • Adenocarcinoma / drug therapy
  • Adenocarcinoma / secondary
  • Aged
  • Antibodies, Monoclonal / administration & dosage
  • Antibodies, Monoclonal / adverse effects*
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents / adverse effects*
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Cetuximab
  • Colonic Neoplasms / drug therapy
  • Colonic Neoplasms / pathology
  • Disease Susceptibility
  • Drug Eruptions / etiology*
  • ErbB Receptors / antagonists & inhibitors*
  • Gefitinib
  • Humans
  • Liver Neoplasms / drug therapy
  • Liver Neoplasms / secondary
  • Lung Neoplasms / drug therapy
  • Lung Neoplasms / secondary
  • Male
  • Neoplasm Proteins / antagonists & inhibitors*
  • Quinazolines / administration & dosage
  • Quinazolines / adverse effects*
  • Staphylococcal Skin Infections / etiology*
  • Superinfection / etiology*

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents
  • Neoplasm Proteins
  • Quinazolines
  • ErbB Receptors
  • Cetuximab
  • Gefitinib